Guardian Pharmacy Services, Inc.
GRDNNYSEHealthcare● Active
$40.64
+$0.16(+0.40%)
Market Cap$2.6B
P/E Ratio—
52W High$41.36
52W Low$19.17
Guardian Pharmacy Services, Inc. (GRDN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GRDN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.45B | $1.23B | $1.05B | $0.91B | $0.79B |
| Cost of Revenue | $1.17B | $0.98B | $0.84B | $0.72B | $0.63B |
| Gross Profit | $0.28B | $0.24B | $0.21B | $0.19B | $0.16B |
| Gross Margin %(computed) | 19.47% | 19.89% | 19.91% | 20.45% | 20.36% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | ($0.00B) | $0.01B |
| Total Operating Expenses | $0.19B | $0.31B | $0.17B | $0.13B | $0.13B |
| Operating Income | $0.09B | ($0.06B) | $0.04B | $0.05B | $0.03B |
| Operating Margin %(computed) | 6.14% | -5.12% | 3.91% | 5.72% | 3.81% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.07B | ($0.07B) | $0.04B | $0.05B | $0.03B |
| Income Tax Expense | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.05B | ($0.09B) | $0.02B | $0.04B | $0.02B |
| Net Margin %(computed) | 3.40% | -7.11% | 2.28% | 3.90% | 2.06% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.79 | $-1.77 | $0.39 | $0.58 | $0.27 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| EBITDA | $0.11B | ($0.04B) | $0.06B | $0.07B | $0.05B |
| EBITDA Margin %(computed) | 7.68% | -3.54% | 5.62% | 7.50% | 5.87% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Guardian Pharmacy Services, Inc. data
About Guardian Pharmacy Services, Inc. (GRDN) Income Statement
Guardian Pharmacy Services, Inc. (GRDN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GRDN reported revenue of $1.45B, gross profit of $0.28B (gross margin 19.47%), and net income of $0.05B — a net profit margin of 3.40%.
Frequently asked questions
GRDN · 4 questionsGuardian Pharmacy Services, Inc. (GRDN) reported revenue of $1.45B for 2025, up 17.9% year-over-year.
GRDN revenueGRDN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08